Maolac uses machine learning and proteomics to identify functional proteins based on breast milk.
Founded in 2018 and based in Yokneam, Israel, Maolac combines proteomics with machine learning and natural language processing to identify functional milk proteins. Its platform uses biological indications and pathway data to predict proteins for different end users; the company has identified 1,500 proteins for various applications. In July 2022, it raised USD 3.2 million in seed funding led by OurCrowd, with Mediterranean Towers Ventures, Naomi Investments, The Food Tech Lab, The Kitchen-FoodTech Hub, and Ventures Israel participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in